Issue 3, 1990

Nucleoside analogues. Part 10. Synthesis of three unusual 5-fluorouracil seco-nucleosides incorporating N-(2-chloroethyl)-N-nitrosourea residues

Abstract

Seco-nucleosides in which 5-fluorouracil (5-FU) is attached at N3 cannot be synthesised when the heteroatom is O by the methods effective when it is S. An N-phthaloyl representative of this class has now been made from a suitably protected pyrimidine and converted into the corresponding N-(2-chloroethyl)-N-nitrosourea (CNU), a molecular combination of anti-tumour drugs of great interest for comparison with other closely related structures. Further, the successful manipulation of the carboxy group in the standard synthetic scheme has led to the preparation of the first molecular combination incorporating this function. Thirdly, hydrazinolysis of phthalimido-CNU's has made possible the construction of complex drugs with both CNU and MNU (N-methyl-N-nitrosourea) moieties, thus achieving regiospecific location of two N-nitroso groups in molecules with four dissimilar urea NH's. All these drugs are undergoing anti-tumour evaluation, the effect of the CNU-MNU combinations on a repair enzyme of DNA metabolism being of additional significance.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 1, 1990, 795-802

Nucleoside analogues. Part 10. Synthesis of three unusual 5-fluorouracil seco-nucleosides incorporating N-(2-chloroethyl)-N-nitrosourea residues

N. M. Lucey, J. E. McCormick and R. S. McElhinney, J. Chem. Soc., Perkin Trans. 1, 1990, 795 DOI: 10.1039/P19900000795

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements